Maravai LifeSciences Reports Third Quarter 2024 Financial Results

MRVI Stock  USD 5.22  0.26  5.24%   
Under 63% of all Maravai Lifesciences' traders are looking to take a long position. The analysis of overall sentiment of trading Maravai Lifesciences Holdings stock suggests that some investors are interested at this time. Maravai Lifesciences' investing sentiment shows overall attitude of investors towards Maravai Lifesciences Holdings.
  
Announces Agreement to Acquire the DNA and RNA business of Officinae Bio, Advancing Support for Innovative Nucleic Acid RD SAN DIEGO, Calif., Nov. 07, 2024 -- Maravai LifeSciences Holdings, Inc. , a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the third quarter ended September 30, 2024, together with other business updates. Financial Highlights Quarterly revenue of 65.

Read at finance.yahoo.com
Yahoo News
  

Maravai Lifesciences Current Investor Sentiment

Panic Vs Confidence

63

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Maravai Lifesciences' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Maravai Lifesciences Holdings.

Maravai Lifesciences Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Maravai Lifesciences can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Maravai Lifesciences Fundamental Analysis

We analyze Maravai Lifesciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Maravai Lifesciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Maravai Lifesciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Probability Of Bankruptcy

Probability Of Bankruptcy Comparative Analysis

Maravai Lifesciences is currently under evaluation in probability of bankruptcy category among its peers. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.

Maravai Lifesciences Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Maravai Lifesciences stock to make a market-neutral strategy. Peer analysis of Maravai Lifesciences could also be used in its relative valuation, which is a method of valuing Maravai Lifesciences by comparing valuation metrics with similar companies.

Peers

Maravai Lifesciences Related Equities

PTGXProtagonist Therapeutics   11.55   
0%
100.0%
APLSApellis Pharmaceuticals   10.88   
0%
94.0%
HALOHalozyme Therapeutics   7.22   
0%
62.0%
ROIVRoivant Sciences   6.01   
0%
52.0%
ASNDAscendis Pharma   5.85   
0%
50.0%
AKROAkero Therapeutics   4.90   
0%
42.0%
ALECAlector   4.79   
0%
41.0%
KRYSKrystal Biotech   4.45   
0%
38.0%
CYTKCytokinetics   3.00   
0%
25.0%
LEGNLegend Biotech   2.99   
0%
25.0%
RAREUltragenyx   2.65   
0%
22.0%
HRMYHarmony Biosciences   2.53   
0%
21.0%
DNLIDenali Therapeutics   1.94   
0%
16.0%
INCYIncyte   1.89   
0%
16.0%
FOLDAmicus Therapeutics   1.68   
0%
14.0%
ARGXArgenx NV   1.54   
0%
13.0%
ABUSArbutus Biopharma   1.45   
0%
12.0%
IMVTImmunovant   1.24   
0%
10.0%
EWTXEdgewise Therapeutics   0.69   
0%
5.0%
AGIOAgios Pharm   0.25   
0%
2.0%
INSMInsmed   0.89   
7.0%
0%
ARQTArcutis Biotherapeutics   0.98   
8.0%
0%

Complementary Tools for Maravai Stock analysis

When running Maravai Lifesciences' price analysis, check to measure Maravai Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Maravai Lifesciences is operating at the current time. Most of Maravai Lifesciences' value examination focuses on studying past and present price action to predict the probability of Maravai Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Maravai Lifesciences' price. Additionally, you may evaluate how the addition of Maravai Lifesciences to your portfolios can decrease your overall portfolio volatility.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Global Correlations
Find global opportunities by holding instruments from different markets